Hyundai Bioscience Co. Ltd (048410) — Cash Flow Quality Index
Hyundai Bioscience Co. Ltd (048410) has a Cash Flow Quality Index of 5.09x as of June 2024. Operating cash flow of ₩8.02 Billion exceeds net income of ₩1.58 Billion, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of Hyundai Bioscience Co. Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hyundai Bioscience Co. Ltd Cash Flow Quality Index (2008–2019)
Historical Cash Flow Quality Index for Hyundai Bioscience Co. Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Hyundai Bioscience Co. Ltd operating cash flow efficiency.
Annual Cash Flow Quality Index for Hyundai Bioscience Co. Ltd (2008–2019)
Year-by-year earnings quality comparison for Hyundai Bioscience Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 11.96x | ₩9.18 Billion | ₩767.22 Million | ▲ +525.8% |
| 2018 | 1.91x | ₩5.01 Billion | ₩2.62 Billion | ▲ +163.0% |
| 2017 | -3.03x | ₩-3.70 Billion | ₩1.22 Billion | ▼ -2570.3% |
| 2015 | 0.12x | ₩87.36 Million | ₩711.29 Million | ▼ -93.8% |
| 2008 | 1.97x | ₩10.37 Billion | ₩5.26 Billion | — |